... anticoagulation (OAC) treatment is used to reduce the risk of stroke in patients with nonvalvular AF (NVAF); however, the risk versus benefit of OAC for advanced CKD is continuously debated. We aim to assess the management and outcomes of NVAF patients with impaired renal function within a population-based cohort...

...Rahul Trikha; Peter R. Kowey Objectives: Dabigatran, rivaroxaban, apixaban, and edoxaban are nonvitamin K antagonist oral anticoagulants (NOACs) approved for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). Phase-3 clinical trials demonstrated NOACs were as effective...

.... Anticoagulants Atrial fibrillation Hemorrhage International normalized ratio Nutrition Stroke Warfarin Atrial fibrillation (AF) is the most commonly observed arrhythmia in clinical practice. As the population continues to age and live longer with risk factors for AF, such as hypertension and heart...

... coronary syndrome Unstable angina Non-Q wave myocardial infarction Antithrombotic therapy Anticoagulants Low-molecular-weight heparin Enoxaparin The acute coronary syndromes of unstable angina (UA) and non-Q wave myocardial infarction (NQMI) account for high numbers of hospital admissions...